Conclusion
In conclusion, our review highlights the significance of potential
drug-drug interactions involving LAI cabotegravir and rilpivirine and
frequently used concomitant medications, particularly in sub-Saharan
African countries. Awareness is crucial, spanning healthcare providers,
PLWH and dispensing outlets, especially where prescription-free
medication access exists.